Guardant Health (GH) Net Income towards Common Stockholders (2017 - 2026)

Guardant Health has disclosed Net Income towards Common Stockholders across 10 years of filings, most recently posting -$112.1 million for Q1 2026.

• Net Income towards Common Stockholders for Q1 2026 came in at -$112.1 million, down 17.78% year-over-year; the trailing twelve-month figure through Mar 2026 was -$433.2 million (down 4.0% YoY), and the FY2025 annual result was -$416.3 million, up 4.61% from the prior year.
• Net Income towards Common Stockholders came in at -$112.1 million for Q1 2026 at Guardant Health, up from -$128.5 million in the prior quarter.
• In the past five years, Net Income towards Common Stockholders ranged from a high of -$72.8 million in Q2 2023 to a low of -$229.4 million in Q2 2022.
• The 5-year median for Net Income towards Common Stockholders is -$112.1 million (2026), against an average of -$123.5 million.
• Across the five-year window, Net Income towards Common Stockholders tumbled 135.13% in 2022 and surged 68.28% in 2023, its largest moves.
• Guardant Health's Net Income towards Common Stockholders stood at -$139.9 million in 2022, then slumped by 33.67% to -$187.0 million in 2023, then surged by 40.65% to -$111.0 million in 2024, then dropped by 15.75% to -$128.5 million in 2025, then climbed by 12.78% to -$112.1 million in 2026.
• The last three Net Income towards Common Stockholders figures came in at -$112.1 million (Q1 2026), -$128.5 million (Q4 2025), and -$92.7 million (Q3 2025), per Business Quant data.